FDA — authorised 29 December 1997
- Marketing authorisation holder: ALCON
- Status: approved
🇺🇸 Emadine in United States
FDA authorised Emadine on 29 December 1997
Marketing authorisations
FDA — authorised 29 December 1997
- Application: NDA020706
- Marketing authorisation holder: NOVARTIS
- Local brand name: EMADINE
- Indication: SOLUTION/DROPS — OPHTHALMIC
- Status: approved
Emadine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Emadine approved in United States?
Yes. FDA authorised it on 29 December 1997; FDA authorised it on 29 December 1997.
Who is the marketing authorisation holder for Emadine in United States?
ALCON holds the US marketing authorisation.